BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32405810)

  • 1. Prognostic significance of T1 mapping parameters in heart failure with preserved ejection fraction: a systematic review.
    Moustafa A; Khan MS; Alsamman MA; Jamal F; Atalay MK
    Heart Fail Rev; 2021 Nov; 26(6):1325-1331. PubMed ID: 32405810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fibrosis and prognosis in heart failure with preserved ejection fraction: a pooled analysis of 12 cohort studies.
    Zhang X; Yang S; Hao S; Li J; Qiu M; Chen H; Huang Y
    Eur Radiol; 2024 Mar; 34(3):1854-1862. PubMed ID: 37658896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiogram-less, free-breathing myocardial extracellular volume fraction mapping in small animals at high heart rates using motion-resolved cardiovascular magnetic reesonance multitasking: a feasibility study in a heart failure with preserved ejection fraction rat model.
    Han P; Zhang R; Wagner S; Xie Y; Cingolani E; Marban E; Christodoulou AG; Li D
    J Cardiovasc Magn Reson; 2021 Feb; 23(1):8. PubMed ID: 33568177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
    Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
    Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.
    Vita T; Gräni C; Abbasi SA; Neilan TG; Rowin E; Kaneko K; Coelho-Filho O; Watanabe E; Mongeon FP; Farhad H; Rassi CH; Choi YL; Cheng K; Givertz MM; Blankstein R; Steigner M; Aghayev A; Jerosch-Herold M; Kwong RY
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1659-1669. PubMed ID: 30448130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
    Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Radiomic MRI based Nomogram for Prediction of Heart Failure with Preserved Ejection Fraction in Systemic Lupus Erythematosus Patients: Insights From a Three-Center Prospective Study.
    Wu LM; Shi RY; Wu CW; Jiang M; Guo Q; Zhu YS; Tang LL; Xu JR; Pu J; Zhou Y; Wu R
    J Magn Reson Imaging; 2022 Sep; 56(3):779-789. PubMed ID: 35049073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Echocardiographic and Cardiac Magnetic Resonance Evaluation Differentiates Among Heart Failure With Preserved Ejection Fraction Patients, Hypertensive Patients, and Healthy Control Subjects.
    Mordi IR; Singh S; Rudd A; Srinivasan J; Frenneaux M; Tzemos N; Dawson DK
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):577-585. PubMed ID: 28823736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
    Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the intravascular and interstitial compartments of remodeled myocardium in heart failure patients with preserved and reduced ejection fraction: a CMR study.
    Masci PG; Pavon AG; Berchier G; Schwitter J
    BMC Med Imaging; 2019 Jan; 19(1):1. PubMed ID: 30611240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.
    Houard L; Amzulescu MS; Colin G; Langet H; Militaru S; Rousseau MF; Ahn SA; Vanoverschelde JJ; Pouleur AC; Gerber BL
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011680. PubMed ID: 33438438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
    Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
    BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Heart Failure Stratification Through Native T1 Mapping: Experience of a Referral Service.
    Marques TDSS; Fernandes AMS; Dantas Júnior RN; Biederman RW; Melo APMO; Aras R
    Arq Bras Cardiol; 2021 May; 116(5):919-925. PubMed ID: 34008815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Value of CMR T
    Rommel KP; Lücke C; Lurz P
    Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):848-855. PubMed ID: 28314659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure with preserved ejection fraction assessed by cardiac magnetic resonance: From clinical uses to emerging techniques.
    He J; Yang W; Jiang Y; Sun X; Zhao S; Weiss R; Sirajuddin A; Lu M
    Trends Cardiovasc Med; 2023 Apr; 33(3):141-147. PubMed ID: 34933114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.